Monoclonal Antibodies Against Autocrine Motility Factor Suppress Gastric Cancer

Oncology Letters - Greece
doi 10.3892/ol.2017.6037
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Tumor Cell Autocrine Motility Factor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Higher Autocrine Motility Factor/Glucose-6-Phosphate Isomerase Expression Is Associated With Tumorigenesis and Poorer Prognosis in Gastric Cancer

Cancer Management and Research
Oncology
2018English

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer

Cancer Research
Cancer ResearchOncology
2009English

Crystal Structures of Autocrine Motility Factor Complexed With Inhibitors

Acta Crystallographica Section A Foundations of Crystallography
2005English

Generation and Characterization of Rat Monoclonal Antibodies Against Epidermal Growth Factor Receptor

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
AllergyImmunology
2015English

Isolation and Characterization of Monoclonal Antibodies Against Eukaryotic Translation Elongation Factor 1A

Biopolymers and Cell
BiochemistryGeneticsMolecular Biology
2003English

Antibodies Against Cancer

BMJ
1956English

Characterization of Monoclonal Antibody GC401 Raised Against Gastric Cancer and Analysis of Phenotypic Expression of Differentiation Antigens in Human Stomach by Monoclonal Antibodies GC302 and GC401.

Japanese Journal of Clinical Immunology
1990English

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy